![Dong-Hui Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dong-Hui Kim
Financieel Directeur/CFO bij
GI INNOVATION, INC.
Vermogen: 8 069 $ op 31-08-2026
Profiel
Dong-Hui Kim is currently Managing Director & Head-Financial Planning at GI Innovation, Inc. since 2024 and serves as an Independent Director at Hana Thirty-six Special Purpose Acquisition Co. Former positions include Manager-Accounting Team at Hana Bank and Manager-Financial Planning Department at Hana Financial Group, Inc. from 2013 to 2015.
Education includes an undergraduate degree from Yonsei University, conferred in 2007.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-08-2026 | 1.350 ( 0% ) | 8 069 $ | 31-08-2026 |
Actieve functies van Dong-Hui Kim
| Bedrijven | Functie | Begin |
|---|---|---|
| GI INNOVATION, INC. | Financieel Directeur/CFO | 01-09-2024 |
Eerdere bekende functies van Dong-Hui Kim
| Bedrijven | Functie | Einde |
|---|---|---|
| HANA FINANCIAL GROUP INC. | Corporate Officer/Principal | 01-12-2015 |
Hana Bank
 Hana Bank Regional BanksFinance Provides banking services | Comptroller/Controller/Auditor | - |
Opleiding van Dong-Hui Kim
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
74
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Hana Bank
Hana Bank Regional BanksFinance Provides banking services | Finance |
Hana Financial Group, Inc.
 Hana Financial Group, Inc. Major BanksFinance Operates as a bank | Finance |
Yonsei University
 Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GI Innovation, Inc.
 GI Innovation, Inc. BiotechnologyHealth Technology Engages in research and development of immunotherapy drugs based on fusion proteins | Health Technology |
